Medical diagnostic devices and methods

Information

  • Patent Grant
  • 10383556
  • Patent Number
    10,383,556
  • Date Filed
    Monday, June 8, 2009
    15 years ago
  • Date Issued
    Tuesday, August 20, 2019
    5 years ago
Abstract
A medical diagnostic device includes a wirelessly transmitted time data receiver and processor. Associated devices, methods and functionality are also described.
Description
FIELD

The present invention is directed to devices and methods possessing one or more of improved timekeeping abilities and functionality, and visual user interfacing capabilities.


BACKGROUND

In this specification where a document, act or item of knowledge is referred to or discussed, this reference or discussion is not an admission that the document, act or item of knowledge or any combination thereof was at the priority date, publicly available, known to the public, part of common general knowledge, or otherwise constitutes prior art under the applicable statutory provisions; or is known to be relevant to an attempt to solve any problem with which this specification is concerned.


Currently, glucose monitors typically include a clock function that allows the device to mark each individual glucose measurement with a timestamp. As the user tests with the device over a period of time, the time data collected and the associated glucose values are used by the patient and their care givers to create charts of glucose measurements. This set of data can be used to adjust patient medication or as a tool to gauge effectiveness of current treatments.


A flaw in current systems is that they are dependent on the users to correctly set the time. Setting the time on a glucose meter is not always a straight forward task and many of the users of glucose meters are older and/or not technologically savvy. It is also very likely that many users of glucose meters are not even aware that they should be setting the time on their devices. The difficulty in correctly setting the time results in many glucose meters collecting inaccurate data that is not useable by patient or caregiver.


A problem with episodic glucose monitoring is that patients only get a snapshot of their current blood glucose. They must make treatment decisions using that snapshot, rather than using dynamic information that more accurately reflects their condition.


For example, if a patient tests and finds that their blood glucose is low, they may decide to take in some carbohydrates to raise their blood sugar. However, it may be that their glucose is already rising, in which case they may not need as much, or any carbohydrates.


Conversely, a patient may test and find that their blood glucose is at a desirable level, not realizing that their glucose is actually rapidly dropping. In this case they will probably decide not to intake any carbohydrates, when in reality they may face a hypoglycemic event soon if they don't act.


It would be desirable for the glucose meter to be able to forecast what direction and how quickly glucose levels are changing. This would allow the user to more accurately treat themselves, thus reducing the likelihood of hypoglycemic or hyperglycemic events.


In order to do such forecasting, at least two things are required: enough historical data in order to predict future trends; and accurate time-stamping information associated with those historical glucose results.


SUMMARY OF THE INVENTION

As used herein, “body fluid” encompasses whole blood, intestinal fluid, and mixtures thereof.


As used herein “integrated device” or “integrated meter” means a device or meter that includes all components necessary to perform sampling of body fluid, transport of body fluid, quantification of an analyte, and display of the amount of analyte contained in the sample of body fluid. Exemplary integrated meters are described in: U.S. Pat. Nos. 6,540,675 and 7,004,928; U.S. Patent Application Publication Nos. US 2008/0077048, US 2007/0179404, US 2007/0083131, US 2007/0179405, US 2007/0078358, and US 2007/0078313. The entire contents of each of the above-listed documents are incorporated herein by reference.


It is to be understood that reference herein to first, second, third and fourth components (etc.) does not limit the present invention to embodiments where each of these components is physically separable from one another. For example, a single physical element of the invention may perform the functions of more than one of the claimed first, second, third or fourth components. Conversely, a plurality of separate physical elements working together may perform the functions of one of the claimed first, second, third or fourth components. Similarly, reference to first, second (etc.) method steps does not limit the invention to only separate steps. According to the invention, a single method step may satisfy multiple steps described herein. Conversely, a plurality of method steps could, in combination, constitute a single method step recited herein. In addition, the steps of the method are not necessarily limited to the order in which they are described or claimed herein.


Advantages provided by the invention over the current technology may optionally include: guaranteeing that any device in which the technology is used will be able to automatically and accurately set the internal clock of the device to local time. When applied to a fully integrated glucose meter this invention may have one or more of the following specific advantages: convenience of never having to set time on the device; assurance that the device's internal clock will always be set to correct local time; significant increase in caregiver's confidence in data collected by meter; improved ability to monitor/detect trends in test results; ability to confidently adjust patient medications based on data collected by meter; allows meter to internally process data using methods not currently used in glucose monitors; can provide users with information not currently available on glucose meters; and providing the user with a clear and constant indication of the number of tests performed or remaining in an integrated meter.


According to a first aspect, the present invention provides a medical diagnostic device comprising means for receiving and processing time data transmitted wirelessly.


According to another aspect, the present invention provides a method for operating a medical diagnostic device, the method comprising: receiving and processing time data transmitted wirelessly.


According to a further aspect, the present invention provides a method of operating a blood glucose meter, the method comprising: receiving and processing time data transmitted wirelessly with the blood glucose meter; performing a plurality of tests with the blood glucose meter; correlating a plurality of glucose concentration measurement values derived from the tests with particular points in time or intervals of time during the day to establish a predetermined range of typical glucose measurement values associated with a particular point in time or time interval; and alerting the user when a measured glucose value falls outside of the predetermined range of typical glucose measurements.


According to yet another aspect, the present invention provides a method of monitoring and treating diabetes with the assistance of a blood glucose meter, the method comprising: receiving and processing time data transmitted wirelessly with the blood glucose meter; performing a plurality of tests with the blood glucose meter; correlating glucose concentration measurement values derived from the tests with the particular points in time during the day when they were taken to establish a data set; downloading the data set from the blood glucose meter; deriving trends based on the downloaded glucose concentration values and associated time data; and prescribing treatment based at least in part on the trends.


According to another alternative aspect, the present invention provides a method of monitoring and treating diabetes with the assistance of a blood glucose meter, the method comprising: receiving and processing time data transmitted wirelessly with the blood glucose meter; performing at least one test with the blood glucose meter thereby creating a blood glucose concentration measurement value; correlating the glucose concentration measurement value with the particular point in time during the day when the test was performed; and automatically identifying the glucose concentration measurement value as being associated with either a pre-prandial test or post-prandial test based at least in part on the correlated time associated with the value, or prompting the user to identify the glucose concentration measurement value as being associated with either a pre-prandial test or post-prandial test.





BRIEF DESCRIPTION OF THE DRAWING FIGURES

The following description of preferred embodiments can be read in connection with the accompanying drawings in which like numerals designate like elements and in which:



FIG. 1 is a schematic illustration of circuitry used to gather and process signals containing time data.



FIG. 2 is a state diagram illustrating methods whereby a diagnostic medical device may process a signal for use in generating accurate time data for use by the device.



FIG. 3 is a schematic illustration of a diagnostic device constructed according to one optional aspect of the present invention.





DETAILED DESCRIPTION

According to certain aspects, the present invention is aimed at a fully integrated glucose meter. However, the present invention is not be limited to integrated glucose meters because its benefits can also be applied to conventional (non-integrated) glucose meters, and other diagnostic devices where collection of long term data and analysis of trends in data is important. In the description that follows the term “device” is used to collectively refer to the abovementioned devices/implementations of the principles of the present invention.


In general terms, when applied to a device, the invention enables the device to use time information commonly available in wireless communications (e.g., radio data system (RDS/RBDS), cell phone, WiFi, etc.) to automatically, quickly, and accurately adjust the internal clock of the device and set it to the correct local time. The invention may include electronic components that when combined give the meter access to time data transmitted wirelessly. Once the correct electronics are in place and the meter can access the information, the data must be carefully processed to ensure that the device is automatically programmed to the correct time. Many electronic components are available that allow access to data in the Radio Broadcast Data Stream (RDS/RBDS). One such component is Si4705 integrated circuit from Silicon Labs. FIG. 1 shows a schematic of such a component, and additional electrical components associated with gathering time data from the RBDS. In addition to the components illustrated in FIG. 1, an antenna may also be provided that allows the integrated circuit to receive RBDS information outdoors and indoors. The antenna can be a simple wire of a specific length optimized to receive RBDS data or any other antenna design to guarantee signal strengths in all intended use environments, homes, offices, cars, parks, etc.


In one alternative embodiment, the integrated circuit and associated electronics are integrated onto the main circuit board assembly of a device.


Collecting data is only one aspect of the invention. Once time data is being collected it is processed in a way that allows the device to accurately and efficiently translate the raw radio signal into a usable time. This involves both hardware and software processing of the signal. One optional method of converting a raw RBDS signal into the correct time on a device is illustrated in state diagram form in FIG. 2.


A summary of what is described in the state diagram follows:

    • 1. The device scans local area for a plurality (e.g., up to 10) best RBDS frequencies based on signal to noise ratio (SNR).
      • a. Scanning for ten signals allows for redundancy should any signal be lost.
      • b. Storing multiple frequencies as a data file also improves the speed at which RBDS time information can be acquired. If a particular frequency does not produce usable time data quickly the meter can change to another frequency without a delay in scanning all frequencies.
      • c. Access to multiple signals also allow for a comparison of the time carried by several signals as a verification of having set the correct time on the device.
      • d. Searching based on SNR ensures that the device can lock in to the signal sources that are nearest to it, and therefore set the correct time for the device's current position.
    • 2. NOTE: To conserve power the device's firmware may also include instructions to incrementally increase the time between searching for useable frequencies if it encounters difficulty finding a useable signal.
      • a. This is illustrated by the “wait” balloon in the top right section of the state diagram.
      • b. This algorithm maximizes battery life.
        • i. Under certain conditions (shipping, storage, travel to very remote locations, etc.) a useable RBDS may be difficult to locate.
        • ii. If the device's program logic was not intelligent enough to determine when to search for a signal it would continue to search until it exhausted its power supply.
    • 3. Once the device has successfully created an internal database of usable RBDS frequencies it begins searching for valid time information.
    • 4. After finding valid time information the device compares the time currently stored in the device with the time carried by the RBDS.
    • 5. If the internally stored time is inconsistent with a verified RBDS time the clock is set to the RBDS time, the device then waits until the next time checking cycle arrives.


Accurately setting the internal clock is only one aspect of the invention. Additional features and benefits that an accurately set clock can provide to a device are also provided by the present invention. The following list is not meant to be exhaustive but is exemplary of some of the potential benefits.


Glucose forecasting will improve the safety of users of an analyte monitor by preventing improper intake of either food or medications.


Option 1—Use Most Recent Previous Test Data


If the user of a device frequently the device can look at the last few tests to determine if a trend can be identified. For example:

7 pm glucose=125 mg/dL→8 pm glucose=68 mg/dL


The device can identify this as a rapidly falling glucose and may alert the user to test again within a set period of time to verify the trend. It is also possible to suggest the user contact their care provider and/or suggest a potential treatment, such as carbohydrate intake.


Option 2—Historical Data


If the user of the device consistently tests around the same time period (i.e., upon waking, hour after lunch, etc.) the meter can “learn” the user's typical trends and suggest appropriate actions. For example, if the device consistently detects potential hypoglycemic events (very low glucose values) at a specific time of day, but on a particular occasion detects normal values at the same time the device may encourage the user to test again within a few minutes to verify that the user's glucose levels are normal and not quickly dropping.


The methods and uses of glucose forecasting are not limited to those previously mentioned.


Another use of a reliably accurate internal-clock is the ability to alert users to retest after an abnormal test result. For example if over a defined period of time the user of the device consistently has measured glucose levels within a particular range the device may “learn” the users typical trending. Once the device has learned the user's trends it may begin to expect particular glucose measurements during a particular time of day. If the user completes a glucose measurement that appears abnormal, i.e., out of typical range for time of day, the device may encourage the user to test again to verify the result. While it is possible that the user's glucose measurement may be out of a typical range due to diet, activity levels or response to medication, it also possible that the device may have miscalculated the real glucose value due to a problem with the device. A common benchmark for glucose monitors is the ability to provide glucose measurements that are accurate +/−20% for 90% of the number of tests. This benchmark demonstrates that the potential for the occasional incorrect glucose measurements is widely accepted.


Many people with diabetes are dependent on medications (oral insulin, injectable insulin, or other oral medications) and other treatment plans to maintain their glucose levels within safe and acceptable ranges. For example, a doctor may ask their patient to test immediately upon waking, and then test an hour after breakfast, lunch and dinner. The doctor may then ask their patient to bring their device to their next office visit. When the patient arrives with a device clinical staff may download all of the data that the meter has collected. This data is then analyzed using many methods to suggest appropriate treatment plans. One typical analysis is to plot all of the patient's glucose values compared to time of day. This results in a plot that shows how patient's glucose levels “trend” throughout the day. The clinical staff can then look the patient's trend plot to determine how much medication to prescribe and when to ask their patient to take the medications. This type of analysis can be very effective in helping patient maintain acceptable glucose levels throughout an entire day.


However, complications can arise if the patient's meter does not have correct time information. If the clinical staff notices that the device has the incorrect time they may be able to offset the data and adjust the trend plot so that treatment plans can still be adjusted. This type of adjustment is dependent on knowing how long the device's internal clock has been improperly set. For example, it would be completely unknown to the clinical staff if the patient's device had correct time for half the results, but then incorrect time for the second half of the results. The clinical staff seeing the incorrect time may then shift every result so that half of them are still incorrect. At best, the clinical staff may decide not to change treatment plans due to lack of confidence in the data. At worst, the clinical staff may incorrectly adjust the treatment plan and unknowingly put the patient at risk.


It is also possible that the clinical staff may not notice that the device has the incorrect time set and may read an incorrect trend plot and adjust the treatment plan incorrectly. Again, this can prevent a patient from improving their disease management or even put the patient at risk for over or under medicating.


Many patients with diabetes receive their treatments at either endocrinologists, or primary care doctors focused on working with these patients. The offices that treat patients with diabetes can therefore see several patients in a given day. To maintain an efficiently running office clinical staff need to quickly be able to collect information from patient's device, process the information, and provide data to the clinical staff to allow them to determine effectiveness of current treatments and create modified treatment plans to improve patient's disease management. The process of collecting data from patient's device is already very time and labor intensive. Each device currently on the market has its own individual data transfer cable and data transfer software. When a meter is processed for data download the clinical staff needs to identify the correct cable, the correct software and then hope that the transfer occurs without any issues. If the clinical staff is distracted by trying to figure out how to properly set the time on a device, valuable time will be wasted. Since every device on the market has an individual user interface, it is not uncommon that the clinical staff would have to look up how to adjust the device's clock in a users guide, wasting even more time. This invention ensures that patient's device is always set correctly and therefore will directly save time and money for clinics providing care for patients with diabetes.


Another way in which this invention provides a time and cost savings for clinics is by speeding up the training that each patient must get when receiving a new device. Currently, it is common practice for clinical staff (Certified Diabetes Educator, etc.) to spend time training each patient when they receive a new device. Such training typically includes basic meter operation, and some time spent setting up the device (user preferences, time of day, etc.). The removal of training for setting the clock will provide an instant time savings. This time saving may seem minimal, but when multiplied by the thousands of patients treated by a clinic every year it is very significant.


One of the key factors that clinical staff monitor in their patients while creating and maintaining treatment plans is the patient's glucose levels before and/or 1-2 hours after eating; these tests are typically called pre-prandial and post-prandial tests. This data can be extracted manually from the data collected by the device by looking at the time a test occurred and assuming it was before or after a particular meal. Another way of collecting this data relies on a feature that some devices have that allow user's to mark a particular test as either pre- or post-prandial. There are deficiencies in both methods.


If the data is manually extracted, the clinical staff must first assume that the time on the device was correct when the data was collected, then be comfortable assuming that data collected during a particular time was either pre or post-prandial, and also be able and willing to dedicate more time to a labor intensive data extraction process.


Data marked by the users of the device can be more accurate, however, this method only works if a user understands how to mark a test, selects the appropriate meal marker, i.e., pre- or post-breakfast, etc., remembers to mark all of their tests so that the averages created can have an accurate and sufficiently large data set.


Another benefit of this invention is that it enables a device to accurately and automatically mark tests as either pre- or post-prandial. The following is one of the many possible logic sequences or operational modes that will allow a device to automatically meal stamp a test.

    • 1. The device automatically sets and maintains internal clock as previously described.
    • 2. Option 1: The device can be automatically setup to group tests as pre- or post-meal depending on time of day
      • a. Ex. Tests between 5-7 am are always marked as pre-breakfast and tests between 9-10 am are always marked as post-breakfast, etc.
    • 3. Option 2: User can setup the device manually so that it “learns” when they have particular meals and use this data to automatically mark tests.
      • a. Ex. User programs device once to know that tests between 6-8 am are pre-breakfast and tests between 9-11 am are post-breakfast, etc.
    • 4. After a user completes a glucose measurement the device can compare the test's timestamp against the internal registry for pre- or post-mea times.
    • 5. If a test falls within one of the meal time windows the device can automatically add a pre- or post-meal marker.
    • 6. Optional: The device can automatically ask the user to verify that the test was pre- or post-meal. This is redundant but can add even more confidence to the dataset and will not require the user to navigate a confusing menu. A simple yes/no prompt is sufficient.
    • 7. Optional: The device can store a continuously updating average of each pre- or post-meal glucose values.
      • a. This average can be quickly accessed using a simple user interface directly on the device.
      • b. Easy access to the data allows clinical staff to make well-informed treatment decisions without needing access to computers, cables, or additional software.


A device formed according to further optional aspects of the present invention is illustrated in FIG. 3. The device 10 may comprise a housing 12 of any suitable form, formed of any suitable material. The device comprises a display 14. The device 10 can be provided with enhanced user interface functionality by providing a visual and/or audible signal of at least one of: the number of tests performed; and the number of test remaining to be performed, by the device. The device 10 may provided with one or more interface devices, such as buttons 16.


As alluded to above, a device 10 in the form of an integrated meter includes all of the necessary components for performing an assay to determine the concentration and/or presence of a target analyte. An integrated meter may in fact, according to the principles of the present invention, be provided with the necessary components for performing a plurality of tests, each capable of determining the presence and/or concentration of a target analyte substance. For example, an integrated meter may optionally be provided with a removable cartridge 18 or similar device which contains the necessary components 20 for performing a plurality of tests. The device 10 may comprise a test port 22 for accessing the components 20 of the cartridge 18 to perform a test. The cartridge may be removed through a door or cover 24 forming part of the housing 12. The number of tests which have been performed, or which are available for use before the cartridge 18 must be replaced, becomes important information to communicate to the user of such devices. According to the present invention, an integrated meter may be provided with the means necessary to produce a suitable audible and/or visual signal to the user to convey such information. Any suitable signal may be utilized. Suitable audible signals may include spoken information concerning the number of test performed and/or remaining. Suitable visual signals may include alphanumeric characters which specify the number of tests performed and/or remaining 15. These visual signals 15 may be continuously displayed by the integrated meter, even when the meter itself is “powered down” or otherwise shut off or placed in a “sleep” mode. According to a further alternative, the integrated meter may be designed such that it is inverted or flipped when it is to be applied to the skin of a user. Thus, according to a further aspect of the present invention, the device may include a suitable means for sensing is inverted or flipped condition and the visual display of alphanumeric characters may likewise be flipped or inverted so as to facilitate reading by the user, regardless of the orientation of the integrated meter.


The device 10 may further comprise a circuit board 26 comprising electronic components. These components may include components for receiving and processing time data transmitted wirelessly, as previously described herein Thus, the device 10 may comprise any of the functionality previously described herein. An integrated circuit 28 for receiving, and optionally at least partially processing, wirelessly transmitted time data may be provided. The integrated circuit 28 may take any suitable form, such as the Si4705 circuit commercially available from Silicon Labs, as previously described herein. The integrated circuit 28 may be provided with a suitable antenna 30, such as a wire-like antenna contained within the housing 12 of the device 10. Other suitable antennas are envisioned, such as external flexible antennas, and the like. The circuit board may further include a number of additional electronic components, such as a processor 32, memory 34 and power supply 36. The processor 32 may optionally cooperate with the integrated circuit 28, and may also process time data received thereby for use by the device 10.


Numbers expressing quantities of ingredients, constituents, reaction conditions, and so forth used in this specification are to be understood as being modified in all instances by the term “about”. Notwithstanding that the numerica ranges and parameters setting forth, the broad scope of the subject matter presented herein are approximations, the numerical values set forth are indicated as precisely as possible. Any numerical value, however, inherently contains certain errors necessarily resulting from the standard deviation found in their respective measurement techniques. None of the elements recited in the appended claims should be interpreted as invoking 35 U.S.C. § 112, ¶6, unless the term “means” is explicitly used.


Although the present invention has been described in connection with preferred embodiments thereof, it will be appreciated by those skilled in the art that additions, deletions, modifications, and substitutions not specifically described may be made without departing from the spirit and scope of the invention as defined in the appended claims.

Claims
  • 1. A method of operating a blood glucose meter, the method comprising: generating a plurality of glucose concentration measurement values from a plurality of tests performed with the blood glucose meter;correlating, using the blood glucose meter, the plurality of glucose concentration measurement values with particular points in time or intervals of time during the day, wherein the correlated plurality of glucose concentration measurements establishes a range of glucose measurement values associated with the particular point in time or time interval;comparing a subsequent measured blood glucose concentration value derived from a subsequent test performed during the particular point in time or time interval to the range of glucose measurement values associated with the particular point in time or time interval; andalerting a user to perform another test when the subsequent measured blood glucose concentration value falls outside of the determined range of glucose measurement values.
  • 2. A method of monitoring and treating diabetes with the assistance of a blood glucose meter, the method comprising: generating a glucose concentration measurement value from at least one test performed with the blood glucose meter;correlating the glucose concentration measurement value with the particular point in time during the day when the test was performed;predicting whether the glucose concentration measurement value is associated with either a pre-prandial test or post-prandial test based at least in part on the correlated time associated with the value, wherein the blood glucose meter provides the prediction; andprompting the user to confirm the prediction made by the blood glucose meter.
  • 3. The method of claim 2, wherein the blood glucose meter comprises predefined time intervals associated with either a pre-prandial test or post-prandial test.
  • 4. The method of claim 2, further comprising programming the blood glucose meter to define the pre-prandial test and post-prandial test time intervals.
  • 5. A method of monitoring and treating diabetes with the assistance of a blood glucose meter, the method comprising: automatically setting a clock of the blood glucose meter by scanning for a plurality of frequencies and receiving and processing time data transmitted wirelessly using one of the plurality of frequencies with the blood glucose meter;performing a plurality of tests with the blood glucose meter to derive a plurality of glucose concentration measurement values;correlating the plurality of glucose concentration measurement values with the particular points in time during the day when they were taken to establish a data set;downloading the data set from the blood glucose meter;deriving trends based on the downloaded glucose concentration values and associated time data; andprescribing treatment based at least in part on the trends.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority to U.S. Provisional Application No. 61/129,148, filed Jun. 6, 2008.

US Referenced Citations (613)
Number Name Date Kind
842690 Oswalt Jan 1907 A
D137874 Partridge May 1944 S
2749797 Harks Mar 1950 A
3092465 Adams, Jr. Jun 1963 A
3310002 Wilburn Mar 1967 A
3620209 Kravitz Nov 1971 A
3623475 Sanz et al. Nov 1971 A
3626929 Sanz et al. Dec 1971 A
3630957 Rey Dec 1971 A
D223165 Komendat Mar 1972 S
3723064 Liotta Mar 1973 A
3741197 Sanz et al. Jun 1973 A
3961898 Neeley et al. Jun 1976 A
3992158 Przybylowicz et al. Nov 1976 A
4014328 Cluff et al. Mar 1977 A
4042335 Clement Aug 1977 A
4057394 Genshaw Nov 1977 A
4109655 Chacornac Aug 1978 A
4250257 Lee et al. Feb 1981 A
4253083 Imamura Feb 1981 A
4254083 Columbus Mar 1981 A
4258001 Pierce et al. Mar 1981 A
4260257 Neeley et al. Apr 1981 A
4289459 Neeley et al. Sep 1981 A
4321397 Nix et al. Mar 1982 A
4350762 DeLuca et al. Sep 1982 A
4394512 Batz Jul 1983 A
4414975 Ryder et al. Nov 1983 A
4416279 Lindner et al. Nov 1983 A
4418037 Katsuyama et al. Nov 1983 A
4422941 Vaughan, Jr. et al. Dec 1983 A
4429700 Thees et al. Feb 1984 A
4627445 Garcia et al. Dec 1986 A
4637403 Garcia et al. Jan 1987 A
4637406 Guinn et al. Jan 1987 A
4653513 Dombrowski Mar 1987 A
4661319 Lape Apr 1987 A
4702261 Cornell et al. Oct 1987 A
4711250 Gilbaugh, Jr. et al. Dec 1987 A
4737458 Batz et al. Apr 1988 A
4767415 Duffy Aug 1988 A
4774192 Terminiello et al. Sep 1988 A
4787398 Garcia et al. Nov 1988 A
4790979 Terminiello et al. Dec 1988 A
4794926 Munsch et al. Jan 1989 A
4815843 Tiefenthaler et al. Mar 1989 A
4829470 Wang May 1989 A
4844095 Chiodo et al. Jul 1989 A
4846785 Cassou et al. Jul 1989 A
4887306 Hwang et al. Dec 1989 A
4920977 Haynes May 1990 A
4929426 Bodai et al. May 1990 A
4930525 Palestrant Jun 1990 A
4935346 Phillips Jun 1990 A
4953552 De Marzo Sep 1990 A
4966646 Zdeblick Oct 1990 A
4983178 Schnell Jan 1991 A
4995402 Smith Feb 1991 A
5029583 Meserol Jul 1991 A
5035704 Lambert et al. Jul 1991 A
5049487 Phillips et al. Sep 1991 A
5050617 Columbus et al. Sep 1991 A
5059394 Phillips et al. Oct 1991 A
5077199 Basagni et al. Dec 1991 A
5094943 Siedel et al. Mar 1992 A
5110724 Hewett May 1992 A
5114350 Hewett May 1992 A
5116759 Klainer et al. May 1992 A
5131404 Neeley et al. Jul 1992 A
5141868 Shanks et al. Aug 1992 A
5145565 Kater et al. Sep 1992 A
5146437 Boucheron Sep 1992 A
5153416 Neeley Oct 1992 A
5164575 Neeley et al. Nov 1992 A
5166498 Neeley Nov 1992 A
5174291 Schoonen et al. Dec 1992 A
5176632 Bernardi Jan 1993 A
5179005 Phillips et al. Jan 1993 A
5183741 Arai et al. Feb 1993 A
5196302 Kidwell Mar 1993 A
5208163 Charlton et al. May 1993 A
5213966 Vuorinen et al. May 1993 A
5217480 Habar et al. Jun 1993 A
5218966 Yamasawa Jun 1993 A
5223219 Subramanian et al. Jun 1993 A
5228972 Osaka et al. Jul 1993 A
5234818 Zimmermann et al. Aug 1993 A
5241969 Carson et al. Sep 1993 A
5251126 Kahn et al. Oct 1993 A
D341848 Bigelow et al. Nov 1993 S
5269800 Davis, Jr. Dec 1993 A
5275159 Griebel Jan 1994 A
5278079 Gubinski et al. Jan 1994 A
5279294 Anderson et al. Jan 1994 A
5288646 Lundsgaard et al. Feb 1994 A
5299571 Mastrototaro Apr 1994 A
5301686 Newman Apr 1994 A
5302513 Mike et al. Apr 1994 A
5304468 Phillips et al. Apr 1994 A
5306623 Kiser et al. Apr 1994 A
5308767 Terashima May 1994 A
5314441 Cusack et al. May 1994 A
5320607 Ishibashi Jun 1994 A
5354537 Moreno Oct 1994 A
5360595 Bell et al. Nov 1994 A
5368047 Suzuki et al. Nov 1994 A
5383512 Jarvis Jan 1995 A
5390671 Lord et al. Feb 1995 A
5395388 Schraga Mar 1995 A
5399316 Yamada Mar 1995 A
5401110 Neeley Mar 1995 A
5402798 Swierczek et al. Apr 1995 A
5426032 Phillips et al. Jun 1995 A
5441513 Roth Aug 1995 A
5451350 Macho et al. Sep 1995 A
5458140 Eppstein et al. Oct 1995 A
5460777 Kitajima et al. Oct 1995 A
5460968 Yoshida et al. Oct 1995 A
5482473 Lord et al. Jan 1996 A
5506200 Hirschkoff et al. Apr 1996 A
5507288 Böcker et al. Apr 1996 A
5508200 Tiffany et al. Apr 1996 A
5510266 Bonner et al. Apr 1996 A
5514152 Smith May 1996 A
5525518 Lundsgaard et al. Jun 1996 A
5527892 Borsotti et al. Jun 1996 A
5563042 Phillips et al. Oct 1996 A
5568806 Cheney, II et al. Oct 1996 A
5569287 Tezuka et al. Oct 1996 A
5575403 Charlton et al. Nov 1996 A
5577499 Teves Nov 1996 A
5582184 Erickson et al. Dec 1996 A
5586553 Halili et al. Dec 1996 A
5591139 Lin et al. Jan 1997 A
5593838 Zanzucchi et al. Jan 1997 A
5611809 Marshall et al. Mar 1997 A
5624458 Lipscher Apr 1997 A
5630986 Charlton et al. May 1997 A
5632410 Moulton et al. May 1997 A
5636632 Bommannan et al. Jun 1997 A
5647851 Pokras Jul 1997 A
5658515 Lee et al. Aug 1997 A
5660791 Brenneman et al. Aug 1997 A
5670031 Hintsche et al. Sep 1997 A
5676850 Reed et al. Oct 1997 A
5680858 Hansen et al. Oct 1997 A
5681484 Zanzucchi et al. Oct 1997 A
5682233 Brinda Oct 1997 A
5697901 Eriksson Dec 1997 A
5700695 Yassinzadeh et al. Dec 1997 A
5701181 Boiarski et al. Dec 1997 A
5701910 Powles et al. Dec 1997 A
D389761 Thomas Jan 1998 S
5705018 Hartley Jan 1998 A
5708247 McAleer Jan 1998 A
5708787 Nakano et al. Jan 1998 A
5715417 Gardien et al. Feb 1998 A
5730753 Morita Mar 1998 A
5735273 Kurnik et al. Apr 1998 A
5736103 Pugh Apr 1998 A
5741211 Renirie et al. Apr 1998 A
5746217 Erickson et al. May 1998 A
5746720 Stouder, Jr. May 1998 A
5757666 Schreiber et al. May 1998 A
5759364 Charlton et al. Jun 1998 A
5766066 Ranniger Jun 1998 A
5771890 Tamada Jun 1998 A
5797693 Jaeger Aug 1998 A
5800420 Gross et al. Sep 1998 A
5801057 Smart et al. Sep 1998 A
5807375 Gross et al. Sep 1998 A
5820570 Erickson et al. Oct 1998 A
5827183 Kurnik et al. Oct 1998 A
5840020 Heinonen et al. Nov 1998 A
5841126 Fossum et al. Nov 1998 A
5843692 Phillips et al. Dec 1998 A
5846837 Thym et al. Dec 1998 A
5851215 Mawhirt et al. Dec 1998 A
5854074 Charlton et al. Dec 1998 A
D403975 Douglas et al. Jan 1999 S
5855801 Lin et al. Jan 1999 A
5856195 Charlton et al. Jan 1999 A
5858194 Bell Jan 1999 A
5866281 Guckel et al. Feb 1999 A
5871494 Simons et al. Feb 1999 A
5879310 Sopp et al. Mar 1999 A
5879326 Godshall et al. Mar 1999 A
5879367 Latterell et al. Mar 1999 A
5885839 Lingane et al. Mar 1999 A
5891053 Sesekura Apr 1999 A
5893870 Talen et al. Apr 1999 A
D411621 Eisenbarth et al. Jun 1999 S
5911711 Pelkey Jun 1999 A
5911737 Lee et al. Jun 1999 A
5912139 Iwata et al. Jun 1999 A
5925021 Castellano et al. Jul 1999 A
5928207 Pisano et al. Jul 1999 A
5930873 Wyser Aug 1999 A
5938679 Freeman et al. Aug 1999 A
5945678 Yanagisawa Aug 1999 A
5951492 Douglas et al. Sep 1999 A
5951493 Douglas et al. Sep 1999 A
5951521 Mastrototaro et al. Sep 1999 A
5954685 Tierney Sep 1999 A
5962215 Douglas et al. Oct 1999 A
5968760 Phillips et al. Oct 1999 A
5968765 Grage et al. Oct 1999 A
5968836 Matzinger et al. Oct 1999 A
5971941 Simons et al. Oct 1999 A
5972294 Smith et al. Oct 1999 A
5986754 Harding Nov 1999 A
5989409 Kurnik et al. Nov 1999 A
5993189 Mueller et al. Nov 1999 A
D417504 Love et al. Dec 1999 S
6001067 Shults et al. Dec 1999 A
6005545 Nishida et al. Dec 1999 A
6010463 Lauks et al. Jan 2000 A
6010519 Mawhirt et al. Jan 2000 A
6014135 Fernandes Jan 2000 A
6014577 Henning et al. Jan 2000 A
6023629 Tamada Feb 2000 A
6027459 Shain et al. Feb 2000 A
6030827 Davis et al. Feb 2000 A
6032059 Henning et al. Feb 2000 A
6036924 Simons et al. Mar 2000 A
6041253 Kost et al. Mar 2000 A
6045753 Loewy et al. Apr 2000 A
6048352 Douglas et al. Apr 2000 A
6050988 Zuck Apr 2000 A
6056701 Duchon et al. May 2000 A
6056734 Jacobsen et al. May 2000 A
6058321 Swayze et al. May 2000 A
6059815 Lee et al. May 2000 A
6061128 Zweig et al. May 2000 A
6063039 Cunningham et al. May 2000 A
6071251 Cunningham et al. Jun 2000 A
6071294 Simons et al. Jun 2000 A
6077660 Wong et al. Jun 2000 A
6080116 Erickson et al. Jun 2000 A
6083196 Trautman et al. Jul 2000 A
6086544 Hibner et al. Jul 2000 A
6090790 Eriksson Jul 2000 A
6091975 Daddona et al. Jul 2000 A
6093156 Cunningham et al. Jul 2000 A
6097831 Wieck et al. Aug 2000 A
6099484 Douglas et al. Aug 2000 A
6100107 Lei et al. Aug 2000 A
6102933 Lee et al. Aug 2000 A
6103033 Say et al. Aug 2000 A
6103197 Werner Aug 2000 A
6106751 Talbot et al. Aug 2000 A
6118126 Zanzucchi Sep 2000 A
6120676 Heller et al. Sep 2000 A
6123861 Santini, Jr. et al. Sep 2000 A
6126899 Woudenberg et al. Oct 2000 A
6132449 Lum et al. Oct 2000 A
6139562 Mauze et al. Oct 2000 A
6142939 Eppstein et al. Nov 2000 A
6152942 Brenneman et al. Nov 2000 A
6162639 Douglas Dec 2000 A
6172743 Kley et al. Jan 2001 B1
6175752 Say et al. Jan 2001 B1
6176865 Mauze et al. Jan 2001 B1
6183434 Eppstein et al. Feb 2001 B1
6183489 Douglas et al. Feb 2001 B1
6187210 Lebouiz et al. Feb 2001 B1
6192891 Gravel et al. Feb 2001 B1
6193873 Ohara et al. Feb 2001 B1
6200296 Dibiasi et al. Mar 2001 B1
6206841 Cunningham et al. Mar 2001 B1
6214626 Meller et al. Apr 2001 B1
6219574 Cormier et al. Apr 2001 B1
6228100 Schraga May 2001 B1
6230051 Cormier et al. May 2001 B1
6231531 Lum et al. May 2001 B1
6241862 McAleer et al. Jun 2001 B1
6242207 Douglas et al. Jun 2001 B1
6245215 Douglas et al. Jun 2001 B1
6251083 Yum et al. Jun 2001 B1
6251260 Heller et al. Jun 2001 B1
6254586 Mann et al. Jul 2001 B1
6255061 Mori et al. Jul 2001 B1
6256533 Yuzhakov et al. Jul 2001 B1
6268162 Phillips et al. Jul 2001 B1
6271045 Douglas et al. Aug 2001 B1
6272364 Kurnik Aug 2001 B1
6283926 Cunningham et al. Sep 2001 B1
6289230 Chaiken et al. Sep 2001 B1
6298254 Tamada Oct 2001 B2
6299578 Kurnik et al. Oct 2001 B1
6299757 Feldman et al. Oct 2001 B1
6306104 Cunningham et al. Oct 2001 B1
6309351 Kurnik et al. Oct 2001 B1
D450711 Istvan et al. Nov 2001 S
6312612 Sherman et al. Nov 2001 B1
6312888 Wong et al. Nov 2001 B1
6315738 Nishikawa et al. Nov 2001 B1
6322808 Trautman et al. Nov 2001 B1
6329161 Heller et al. Dec 2001 B1
6331266 Powell et al. Dec 2001 B1
6332871 Douglas et al. Dec 2001 B1
6334856 Allen et al. Jan 2002 B1
6350273 Minagawa et al. Feb 2002 B1
6352514 Douglas et al. Mar 2002 B1
6356776 Berner et al. Mar 2002 B1
6358265 Thorne, Jr. et al. Mar 2002 B1
6364890 Lum et al. Apr 2002 B1
6375626 Allen et al. Apr 2002 B1
6375627 Mauze et al. Apr 2002 B1
6379969 Mauze et al. Apr 2002 B1
6391005 Lum et al. May 2002 B1
6391645 Huang et al. May 2002 B1
6402704 McMorrow Jun 2002 B1
6409679 Pyo Jun 2002 B2
6428664 BhulLar et al. Aug 2002 B1
6449608 Morita et al. Sep 2002 B1
6455324 Douglas Sep 2002 B1
6493069 Nagashimada et al. Dec 2002 B1
6500134 Cassone Dec 2002 B1
6520973 McGarry Feb 2003 B1
6530892 Kelly Mar 2003 B1
6537243 Henning et al. Mar 2003 B1
6540675 Aceti et al. Apr 2003 B2
6544475 Douglas et al. Apr 2003 B1
6549796 Sohrab Apr 2003 B2
6555061 Leong et al. Apr 2003 B1
6558624 Lemmon et al. May 2003 B1
6579690 Bonnecaze et al. Jun 2003 B1
6589260 Schmelzeisen-Redeker et al. Jul 2003 B1
6591125 Buse et al. Jul 2003 B1
6602205 Erickson et al. Aug 2003 B1
6612111 Hodges et al. Sep 2003 B1
6616616 Fritz et al. Sep 2003 B2
6626874 Duchamp Sep 2003 B1
6656167 Numao et al. Dec 2003 B2
6679852 Schmelzeisen-Redeker et al. Jan 2004 B1
6706000 Perez et al. Mar 2004 B2
6706049 Moerman Mar 2004 B2
6706159 Moerman et al. Mar 2004 B2
6707554 Miltner et al. Mar 2004 B1
6740800 Cunningham May 2004 B1
6743635 Neel et al. Jun 2004 B2
6748275 Lattner et al. Jun 2004 B2
6753187 Cizdziel et al. Jun 2004 B2
6766817 da Silva Jul 2004 B2
6793633 Douglas et al. Sep 2004 B2
6830669 Miyazaki et al. Dec 2004 B2
6836678 Tu Dec 2004 B2
6837858 Cunningham et al. Jan 2005 B2
6847451 Pugh Jan 2005 B2
6849052 Uchigaki et al. Feb 2005 B2
6896850 Subramanian et al. May 2005 B2
6918404 Da Silva Jul 2005 B2
6919960 Hansen et al. Jul 2005 B2
6923764 Aceti et al. Aug 2005 B2
6936476 Anderson et al. Aug 2005 B1
D511214 Sasano et al. Nov 2005 S
6988996 Roe et al. Jan 2006 B2
7004928 Aceti et al. Feb 2006 B2
7011630 Desai et al. Mar 2006 B2
7025774 Freeman et al. Apr 2006 B2
D519868 Sasano et al. May 2006 S
7052652 Zanzucchi et al. May 2006 B2
7066586 Da Silva Jun 2006 B2
7066890 Lam et al. Jun 2006 B1
7141058 Briggs et al. Nov 2006 B2
7156809 Quy Jan 2007 B2
7163616 Vreeke et al. Jan 2007 B2
7192061 Martin Mar 2007 B2
D540343 Cummins Apr 2007 S
7223365 Von Der Goltz May 2007 B2
7225008 Ward et al. May 2007 B1
7226461 Boecker et al. Jun 2007 B2
7258673 Racchini et al. Aug 2007 B2
D551243 Young Sep 2007 S
7270970 Anderson et al. Sep 2007 B2
7297151 Boecker et al. Nov 2007 B2
7299081 Mace et al. Nov 2007 B2
7343188 Sohrab Mar 2008 B2
7344507 Briggs et al. Mar 2008 B2
7379167 Mawhirt et al. May 2008 B2
7427377 Zanzucchi et al. Sep 2008 B2
D580068 Shigesada et al. Nov 2008 S
D580558 Shigesada et al. Nov 2008 S
D599373 Kobayashi et al. Sep 2009 S
D601257 Berlinger Sep 2009 S
7585278 Aceti et al. Sep 2009 B2
D601444 Jones et al. Oct 2009 S
D601578 Poulet et al. Oct 2009 S
7682318 Alden et al. Mar 2010 B2
D622393 Gatrall et al. Aug 2010 S
7780631 Lum et al. Aug 2010 B2
7803123 Perez et al. Sep 2010 B2
7850621 Briggs et al. Dec 2010 B2
7879058 Ikeda Feb 2011 B2
7887494 Emery et al. Feb 2011 B2
D642191 Barnett et al. Jul 2011 S
7988644 Freeman et al. Aug 2011 B2
8012103 Escutia et al. Sep 2011 B2
8012104 Escutia et al. Sep 2011 B2
8105849 McDevitt et al. Jan 2012 B2
D654926 Lipman et al. Feb 2012 S
8173439 Petrich et al. May 2012 B2
8184273 Dosmann et al. May 2012 B2
8231832 Zanzucchi et al. Jul 2012 B2
8251920 Vreeke et al. Aug 2012 B2
8298255 Conway et al. Oct 2012 B2
8303518 Aceti et al. Nov 2012 B2
8360993 Escutia et al. Jan 2013 B2
8360994 Escutia et al. Jan 2013 B2
8372015 Escutia et al. Feb 2013 B2
8376959 Deck Feb 2013 B2
8382681 Escutia et al. Feb 2013 B2
8391940 Matzinger et al. Mar 2013 B2
D691174 Lipman et al. Oct 2013 S
8574168 Freeman et al. Nov 2013 B2
8702624 Alden Apr 2014 B2
8795201 Escutia et al. Aug 2014 B2
8801631 Escutia et al. Aug 2014 B2
8919605 Lipman et al. Dec 2014 B2
8969097 Emery et al. Mar 2015 B2
9060723 Escutia et al. Jun 2015 B2
9060727 Saikley et al. Jun 2015 B2
9095292 Zanzucchi et al. Aug 2015 B2
9149215 Werner et al. Oct 2015 B2
9366636 Emery et al. Jun 2016 B2
9380974 Litherland et al. Jul 2016 B2
9603562 Aceti et al. Mar 2017 B2
9636051 Emery et al. May 2017 B2
9782114 Reynolds et al. Oct 2017 B2
9833183 Escutia et al. Dec 2017 B2
9839384 Escutia et al. Dec 2017 B2
9897610 Lipman et al. Feb 2018 B2
20010001034 Douglas May 2001 A1
20010027277 Klitmose Oct 2001 A1
20010027328 Lum et al. Oct 2001 A1
20010053891 Ackley Dec 2001 A1
20020002326 Causey, III et al. Jan 2002 A1
20020002344 Douglas et al. Jan 2002 A1
20020004640 Conn et al. Jan 2002 A1
20020006355 Whitson Jan 2002 A1
20020016568 Lebel et al. Feb 2002 A1
20020020688 Sherman et al. Feb 2002 A1
20020022934 Vogel et al. Feb 2002 A1
20020023852 Mcivor et al. Feb 2002 A1
20020042594 Lum et al. Apr 2002 A1
20020045243 Laska et al. Apr 2002 A1
20020052618 Haar et al. May 2002 A1
20020087056 Aceti et al. Jul 2002 A1
20020136667 Subramanian et al. Sep 2002 A1
20020137998 Smart et al. Sep 2002 A1
20020160520 Orloff et al. Oct 2002 A1
20020168290 Yuzhakov et al. Nov 2002 A1
20020169394 Eppstein et al. Nov 2002 A1
20020169411 Sherman et al. Nov 2002 A1
20020177761 Orloff et al. Nov 2002 A1
20020177764 Sohrab Nov 2002 A1
20020183102 Withers et al. Dec 2002 A1
20020188223 Perez et al. Dec 2002 A1
20020198444 Uchigaki et al. Dec 2002 A1
20030012693 Otillar et al. Jan 2003 A1
20030028087 Yuzhakov et al. Feb 2003 A1
20030028125 Yuzhakov et al. Feb 2003 A1
20030039587 Niermann Feb 2003 A1
20030060730 Perez Mar 2003 A1
20030083685 Freeman et al. May 2003 A1
20030083686 Freeman et al. May 2003 A1
20030105961 Zatloukal et al. Jun 2003 A1
20030116596 Terasawa Jun 2003 A1
20030135166 Gonnelli Jul 2003 A1
20030135333 Aceti Jul 2003 A1
20030143746 Sage Jul 2003 A1
20030153844 Smith et al. Aug 2003 A1
20030153900 Aceti et al. Aug 2003 A1
20030175987 Verdonk et al. Sep 2003 A1
20030206302 Pugh Nov 2003 A1
20030207441 Eyster et al. Nov 2003 A1
20030208113 Mault et al. Nov 2003 A1
20030208140 Pugh Nov 2003 A1
20030211619 Olson et al. Nov 2003 A1
20030212344 Yuzhakov et al. Nov 2003 A1
20030212345 McAllister et al. Nov 2003 A1
20030212347 Sohrab Nov 2003 A1
20030216628 Bortz et al. Nov 2003 A1
20040010207 Flaherty et al. Jan 2004 A1
20040030353 Schmelzeisen-redeker et al. Feb 2004 A1
20040039303 Wurster et al. Feb 2004 A1
20040049219 Briggs et al. Mar 2004 A1
20040059256 Perez Mar 2004 A1
20040072357 Stiene et al. Apr 2004 A1
20040073140 Douglas Apr 2004 A1
20040092842 Boecker et al. May 2004 A1
20040092995 Boecker et al. May 2004 A1
20040094432 Neel et al. May 2004 A1
20040096959 Stiene et al. May 2004 A1
20040097796 Berman et al. May 2004 A1
20040098009 Boecker et al. May 2004 A1
20040102803 Boecker et al. May 2004 A1
20040122339 Roe et al. Jun 2004 A1
20040132167 Rule et al. Jul 2004 A1
20040138588 Saikley et al. Jul 2004 A1
20040155084 Brown Aug 2004 A1
20040157339 Burke et al. Aug 2004 A1
20040178218 Schomakers et al. Sep 2004 A1
20040186394 Roe et al. Sep 2004 A1
20040191119 Zanzucchi et al. Sep 2004 A1
20040202576 Aceti et al. Oct 2004 A1
20040230216 LeVaughn et al. Nov 2004 A1
20040236251 Roe et al. Nov 2004 A1
20040238675 Banaszkiewicz et al. Dec 2004 A1
20040242982 Sakata et al. Dec 2004 A1
20040249253 Racchini et al. Dec 2004 A1
20040259180 Burke et al. Dec 2004 A1
20050004494 Perez et al. Jan 2005 A1
20050010134 Douglas et al. Jan 2005 A1
20050015020 LeVaughn et al. Jan 2005 A1
20050038680 McMahon Feb 2005 A1
20050070819 Poux et al. Mar 2005 A1
20050096686 Allen May 2005 A1
20050106713 Phan et al. May 2005 A1
20050109386 Marshall May 2005 A1
20050159678 Taniike et al. Jul 2005 A1
20050187532 Thurau et al. Aug 2005 A1
20050192492 Cho et al. Sep 2005 A1
20050202567 Zanzucchi et al. Sep 2005 A1
20050202733 Yoshimura et al. Sep 2005 A1
20050209518 Sage, Jr. et al. Sep 2005 A1
20050215872 Berner et al. Sep 2005 A1
20050215923 Wiegel Sep 2005 A1
20050234494 Conway et al. Oct 2005 A1
20050245844 Mace et al. Nov 2005 A1
20050255001 Padmaabhan et al. Nov 2005 A1
20050277972 Wong et al. Dec 2005 A1
20060008389 Sacherer et al. Jan 2006 A1
20060036134 Tarassenko et al. Feb 2006 A1
20060052724 Roe Mar 2006 A1
20060064035 Wang et al. Mar 2006 A1
20060079809 Goldberger et al. Apr 2006 A1
20060094985 Aceti et al. May 2006 A1
20060117616 Jones et al. Jun 2006 A1
20060122536 Haar et al. Jun 2006 A1
20060135873 Karo et al. Jun 2006 A1
20060155317 List Jul 2006 A1
20060161078 Schraga Jul 2006 A1
20060178600 Kennedy et al. Aug 2006 A1
20060189908 Kennedy Aug 2006 A1
20060204399 Freeman et al. Sep 2006 A1
20060229533 Hoenes et al. Oct 2006 A1
20060241517 Fowler et al. Oct 2006 A1
20060257993 Mcdevitt et al. Nov 2006 A1
20060259102 Slatkine Nov 2006 A1
20060281187 Emery et al. Dec 2006 A1
20070016104 Jansen et al. Jan 2007 A1
20070017824 Rippeth et al. Jan 2007 A1
20070033074 Nitzan et al. Feb 2007 A1
20070060842 Alvarez-Icaza et al. Mar 2007 A1
20070078313 Emery et al. Apr 2007 A1
20070078358 Escutia et al. Apr 2007 A1
20070083130 Thomson et al. Apr 2007 A1
20070083131 Escutia et al. Apr 2007 A1
20070093786 Goldsmith et al. Apr 2007 A1
20070112281 Olson May 2007 A1
20070179404 Escutia et al. Aug 2007 A1
20070179405 Emery et al. Aug 2007 A1
20070253531 Okuzawa et al. Nov 2007 A1
20070255181 Alvarez-icaza et al. Nov 2007 A1
20070255302 Koeppel et al. Nov 2007 A1
20080046831 Imai et al. Feb 2008 A1
20080077048 Escutia et al. Mar 2008 A1
20080139910 Mastrototaro et al. Jun 2008 A1
20080194934 Ray et al. Aug 2008 A1
20080268485 Guarino et al. Oct 2008 A1
20080269625 Halperin et al. Oct 2008 A1
20090054810 Zanzucchi et al. Feb 2009 A1
20090149717 Brauer et al. Jun 2009 A1
20090156923 Power et al. Jun 2009 A1
20090292489 Burke et al. Nov 2009 A1
20090301899 Hodges et al. Dec 2009 A1
20100010374 Escutia et al. Jan 2010 A1
20100021947 Emery et al. Jan 2010 A1
20100021948 Lipman et al. Jan 2010 A1
20100095229 Dixon et al. Apr 2010 A1
20100174211 Frey et al. Jul 2010 A1
20100185120 Sacherer et al. Jul 2010 A1
20100217155 Poux et al. Aug 2010 A1
20100331650 Batman et al. Dec 2010 A1
20110098599 Emery et al. Apr 2011 A1
20110105872 Chickering et al. May 2011 A1
20110201909 Emery et al. Aug 2011 A1
20110294152 Lipman et al. Dec 2011 A1
20120166090 Lipman et al. Jun 2012 A1
20120271197 Castle et al. Oct 2012 A1
20120296179 Zanzucchi et al. Nov 2012 A1
20130110516 Abulhaj et al. May 2013 A1
20130158430 Aceti et al. Jun 2013 A1
20130158432 Escutia et al. Jun 2013 A1
20130172698 Reynolds et al. Jul 2013 A1
20130274568 Escutia et al. Oct 2013 A1
20130274579 Richter et al. Oct 2013 A1
20140012116 Okuyama Jan 2014 A1
20140316301 Escutia et al. Oct 2014 A1
20140336480 Escutia et al. Nov 2014 A1
20140376762 Lipman et al. Dec 2014 A1
20150037898 Baldus et al. Feb 2015 A1
20150153351 Lipman et al. Jun 2015 A1
20150238131 Richter et al. Aug 2015 A1
20160038066 Escutia et al. Feb 2016 A1
20160367178 Emery et al. Dec 2016 A1
20170095188 Emery et al. Apr 2017 A1
20170319121 Aceti et al. Nov 2017 A1
20170354355 Emery et al. Dec 2017 A1
20180008178 Escutia et al. Jan 2018 A1
20180214059 Escutia et al. Aug 2018 A1
Foreign Referenced Citations (206)
Number Date Country
2 201 530 Sep 1997 CA
2 513 465 Aug 2004 CA
197 05 091 Feb 1999 DE
199 22 413 Nov 2000 DE
103 02-501 Aug 2004 DE
0 103 426 Mar 1984 EP
0 256 806 Feb 1988 EP
0 396-016 Nov 1990 EP
0 396-016 Nov 1990 EP
0 397 424 Nov 1990 EP
0 762 311 Mar 1997 EP
0 255-338 Feb 1998 EP
0 849 584 Jun 1998 EP
1 266-607 Dec 2002 EP
1 266-607 Dec 2002 EP
1 369 688 Oct 2003 EP
1 360-934 Nov 2003 EP
1 360-934 Nov 2003 EP
1 486-766 Dec 2004 EP
1 486-766 Dec 2004 EP
1 529-489 May 2005 EP
1 529-489 May 2005 EP
1 769-735 Apr 2007 EP
1 987 766 Nov 2008 EP
63-305841 Dec 1988 JP
3-63570 Mar 1991 JP
03093189 Apr 1991 JP
7-67861 Mar 1995 JP
7-213925 Aug 1995 JP
9-168530 Jun 1997 JP
9-313465 Sep 1997 JP
9-266889 Oct 1997 JP
9-294737 Nov 1997 JP
10-024028 Jan 1998 JP
10-505258 May 1998 JP
10-508518 Aug 1998 JP
10-318970 Dec 1998 JP
11056822 Mar 1999 JP
11281779 Oct 1999 JP
2000-116629 Apr 2000 JP
2000-126161 May 2000 JP
2000-168754 Jun 2000 JP
2000-254111 Sep 2000 JP
2001-159618 Jun 2001 JP
2001-515203 Sep 2001 JP
2001-305096 Oct 2001 JP
2001-330581 Nov 2001 JP
2002-502045 Jan 2002 JP
2002-085384 Mar 2002 JP
2002-514453 May 2002 JP
2002-168862 Jun 2002 JP
2003-507719 Feb 2003 JP
2003-108679 Apr 2003 JP
2003-180417 Jul 2003 JP
2004-000598 Jan 2004 JP
2004-500948 Jan 2004 JP
2004-117339 Apr 2004 JP
2004-202256 Jul 2004 JP
2004-209266 Jul 2004 JP
2004-519302 Jul 2004 JP
2004-522500 Jul 2004 JP
2004-528936 Sep 2004 JP
2005-503538 Feb 2005 JP
2005-087613 Apr 2005 JP
2006-512969 Apr 2005 JP
3638958 Apr 2005 JP
2005-525149 Aug 2005 JP
2005-237938 Sep 2005 JP
2005-525846 Sep 2005 JP
2005-527254 Sep 2005 JP
2006-506185 Feb 2006 JP
2006-512974 Apr 2006 JP
2006-516723 Jul 2006 JP
2006-521555 Sep 2006 JP
2006-527013 Nov 2006 JP
2007-054407 Mar 2007 JP
2007-067698 Mar 2007 JP
2007-521031 Aug 2007 JP
2007-527287 Sep 2007 JP
2007-311196 Nov 2007 JP
2007-537804 Dec 2007 JP
2008-125813 Jun 2008 JP
2008-212324 Sep 2008 JP
2012-213477 Nov 2012 JP
WO-8605966 Oct 1986 WO
WO-8800812 Feb 1988 WO
WO-8807666 Oct 1988 WO
WO-9114212 Sep 1991 WO
WO-9413203 Jun 1994 WO
WO-9510223 Apr 1995 WO
WO-9510223 Apr 1995 WO
WO-9604857 Feb 1996 WO
WO-9607907 Mar 1996 WO
WO-9614026 May 1996 WO
WO-9625088 Aug 1996 WO
WO-9715227 May 1997 WO
WO-9729847 Aug 1997 WO
WO-9730344 Aug 1997 WO
WO-9741421 Nov 1997 WO
WO-9742885 Nov 1997 WO
WO-9742888 Nov 1997 WO
WO-9743962 Nov 1997 WO
WO-9800193 Jan 1998 WO
WO-9831275 Jul 1998 WO
WO-9835225 Aug 1998 WO
WO-9912008 Mar 1999 WO
WO-9923492 May 1999 WO
WO-9944508 Sep 1999 WO
WO-9956954 Nov 1999 WO
WO-9958051 Nov 1999 WO
WO-9962576 Dec 1999 WO
WO-0009184 Feb 2000 WO
WO-0013573 Mar 2000 WO
WO-0014269 Mar 2000 WO
WO-0014535 Mar 2000 WO
WO-0018449 Apr 2000 WO
WO-0018449 Apr 2000 WO
WO-0019185 Apr 2000 WO
WO-0036400 Jun 2000 WO
WO-0042422 Jul 2000 WO
WO-0074763 Dec 2000 WO
WO-0074763 Dec 2000 WO
WO-0078208 Dec 2000 WO
WO-0113795 Mar 2001 WO
WO-0116575 Mar 2001 WO
WO-0152727 Jul 2001 WO
WO-0164105 Sep 2001 WO
WO-0164105 Sep 2001 WO
WO-0172220 Oct 2001 WO
WO-0180728 Nov 2001 WO
WO-0185233 Nov 2001 WO
WO-0185233 Nov 2001 WO
WO-0191634 Dec 2001 WO
WO-0191634 Dec 2001 WO
WO-0200101 Jan 2002 WO
WO-0200101 Jan 2002 WO
WO-0249507 Jun 2002 WO
WO-0249509 Jun 2002 WO
WO-0249509 Jun 2002 WO
WO-02078533 Oct 2002 WO
WO-02078533 Oct 2002 WO
WO-02082052 Oct 2002 WO
WO-02082052 Oct 2002 WO
WO-02093144 Nov 2002 WO
WO-02100251 Dec 2002 WO
WO-02100251 Dec 2002 WO
WO-02101359 Dec 2002 WO
WO-02101359 Dec 2002 WO
WO-03007819 Jan 2003 WO
WO-2003030984 Apr 2003 WO
WO-2003066128 Aug 2003 WO
WO-2003066128 Aug 2003 WO
WO-2003070099 Aug 2003 WO
WO-2003071940 Sep 2003 WO
WO-2004045375 Jun 2004 WO
WO-2004045375 Jun 2004 WO
WO-2004062499 Jul 2004 WO
WO-2004062500 Jul 2004 WO
WO-2004062500 Jul 2004 WO
WO-2004064636 Aug 2004 WO
WO-2004085995 Oct 2004 WO
WO-2004085995 Oct 2004 WO
WO-2004091693 Oct 2004 WO
WO-2004091693 Oct 2004 WO
WO-2004105827 Dec 2004 WO
WO-2004105827 Dec 2004 WO
WO-2005006939 Jan 2005 WO
WO-2005006939 Jan 2005 WO
WO-2005009238 Feb 2005 WO
WO-2005013824 Feb 2005 WO
WO-2005018709 Mar 2005 WO
WO-2005018709 Mar 2005 WO
WO-2005018710 Mar 2005 WO
WO-2005018710 Mar 2005 WO
WO-2005084543 Sep 2005 WO
WO-2005084546 Sep 2005 WO
WO-2005084546 Sep 2005 WO
WO-2005085995 Sep 2005 WO
WO-2005112763 Dec 2005 WO
WO-2006138226 Dec 2006 WO
WO-2006138226 Dec 2006 WO
WO-2007041062 Apr 2007 WO
WO-2007041062 Apr 2007 WO
WO-2007041063 Apr 2007 WO
WO-2007041063 Apr 2007 WO
WO-2007041244 Apr 2007 WO
WO-2007041244 Apr 2007 WO
WO-2007041287 Apr 2007 WO
WO-2007041287 Apr 2007 WO
WO-2007041355 Apr 2007 WO
WO-2007041355 Apr 2007 WO
WO-2007108519 Sep 2007 WO
WO-2007112034 Oct 2007 WO
WO-2007112034 Oct 2007 WO
WO-2007131036 Nov 2007 WO
WO-2008027319 Mar 2008 WO
WO-2008027319 Mar 2008 WO
WO-2008062648 May 2008 WO
WO-2009145920 Dec 2009 WO
WO-2009148624 Dec 2009 WO
WO-2009148626 Dec 2009 WO
WO-2011065981 Jun 2011 WO
WO-2011162823 Dec 2011 WO
WO-2012127870 Sep 2012 WO
WO-2013020103 Feb 2013 WO
WO-2014205412 Dec 2014 WO
Non-Patent Literature Citations (183)
Entry
Notification of Transmittal of the International Search Report and the Written Opinion of the International Searching Authority Forms (PCT/ISA/220, PCT/ISA/210and PCT/ISA/237) issued in corresponding International Application No. PCT/US 09/03445 dated Jul. 28, 2009.
ADA Consensus Development Panel. (Jan.-Feb. 1987). “Consensus Statement on Self-Monitoring of Blood Glucose,” Diabetes Care 10(1):95-99.
ADA (Jan. 1994). “Self-Monitoring of Blood Glucose,” Consensus Statement Diabetes Care 17(1):81-86.
Anonymous. (Sep. 30, 1993). “The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus.” The New England Journal of Medicine 329(14):977-986.
Anonymous. (Jun. 23, 1998). Taking the “Ouch” Out of Needles: Arrays of “Microneedles” Offer New Techniques for Drug Delivery, Science Daily, located at <http:www.sciencedaily.com/releases/1998/06/980623045850.htm>, last visited Jan. 14, 2014, 3 pages.
Beregszàszi, M. et al. (Jul. 1997). “Nocturnal Hypoglycemia in Children and Adolescents with Insulin-Dependent Diabetes Mellitus: Prevalence and Risk Factors,” J. Pediatrics 131(1 Pt. 1):27-33.
Chase, H.P. et al. (Feb. 2001). “Continuous Subcutaneous Glucose Monitoring in Children with Type 1 Diabetes,” Pediatrics 107(2):222-226.
Clarke, W.L. et al. (Sep.-Oct. 1987). “Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose,” Diabetes Care 10(5):622-628.
Collison, M.E. et al. (Sep. 1999). “Analytical Characterization of Electrochemical Biosensor Test Strips for Measurement of Glucose in Low-Volume Interstitial Fluid Samples,” Clinical Chemistry 45(9):1665-1673.
Coster, S. et al. (2000). “Monitoring Blood Glucose Control in Diabetes Mellitus: A Systematic Review.” Health Technology Assessment 4(12):1-93.
Cox, D.J. et al. (Jun. 1997). “Understanding Error Grid Analysis,” Diabetes Care 20(6):911-912.
D'Arrigo, T.D. (Mar. 2000). “GlucoWatch Monitor Poised for Approval,” Diabetes Forecast, 53(3):43-44.
Feldman, B. et al. (2000). “FreeStyle™: A Small-Volume Electrochemical Glucose Sensor for Home Blood Glucose Testing,” Diabetes Technology and Therapeutics, 2(2):221-229.
Johnson, R.N. et al. (Jan. 1998). “Accuracy of Devices Used for Self-Monitoring of Blood Glucose,” Annals of Clinical Biochemistry 35(1):68-74.
Johnson, R.N. et al. (Jan. 1999). “Analytical Error of Home Glucose Monitors: A Comparison of 18 Systems,” Annals of Clinical Biochemistry 36(1):72-79.
Johnson, R.N. et al. (2001). “Error Detection and Measurement in Glucose Monitors,” Clinica Chimica Acta 307:61-67.
Kumetrix, Inc. (Dec. 1999). “Painless Blood Glucose Monitoring, Courtesy of the Mosquito,” Start-Up pp. 27-28.
Lee, S-C. (Jun. 1999). “Light Scattering by Closely Spaced Parallel Cylinders Embedded in a Finite Dielectric Slab,” Journal of the Optical Society of America A 16(6):1350-1361.
McGarraugh, G. et al. (2001). “Physiological Influences on Off-Finger Glucose Testing,” Diabetes Technology & Therapeutics 3(3):367-376.
McNichols, R.J. et al. (Jan. 2000). “Optical Glucose Sensing in Biological Fluids: An Overview,” Journal of Biomedical Optics, 5(1):5-16.
Mahler, R.J. et al. (1999). “Clinical Review 102, Type 2 Diabetes Melitus: Update on Diagnosis Pathophysiology, and Treatment,” The Journal of Clinical Endocrinology and Metabolism 84(4):1165-1171.
Medline Plus. (Jun. 17, 2008). , Medical Encyclopedia, Monitor Blood Glucose-Series: Part 1-4, 6 pages.
Neeley, W.E. et al. (1981). “An Instrument for Digital Matrix Photometry,” Clinical Chemistry 27(10):1665-1668.
Neeley, W.E. (1983). “Reflectance Digital Matrix Photometry,” Clinical Chemistry 29(6):1038-1041.
Neeley, W.E. (1983). “Multilayer Film Analysis for Glucose in 1-μL Samples of Plasma,” Clinical Chemistry 29(12):2103-2105.
Neeley, W.E. (1988). “A Reflectance Photometer with a Square Photodiode Array Detector for Use on Multilayer Dry-Film Slides,” Clinical Chemistry 34(11):2367-2370.
Otto, E. et al. (2000). “An Intelligent Diabetes Software Prototype: Predicting Blood Glucose Levels and Recommending Regimen Changes,” Diabetes Technology and Therapeutics 2(4):569-576.
Pfohl, M. et al. (2000). “Spot Glucose Measurement in Epidermal Interstitial Fluid—An Alternative to Capillary Blood Glucose Estimation,” Experimental and Clinical Endocrinology & Diabetes 108(1):1-4.
Princen, H.M. (May 1969). “Capillary Phenomena in Assemblies of Parallel Cylinders, I. Capillary Rise Between Two Cylinders,” Journal of Colloid and Interface Science 30(1):69-75.
Princen, H.M. (Jul. 1969). “Capillary Phenomena in Assemblies of Parallel Cylinders, II. Capillary Rise in Systems with More Than Two Cylinders,” Journal of Colloid and Interface Science 30(3):359-371.
Rebrin, K. et al. (Sep. 1999). “Subcutaneous Glucose Predicts Plasma Glucose Independent of Insulin: Implications for Continuous Monitoring,” American Journal of Physiology 277(3):E561-E571.
Rosen, S. (1999). “Road to New-Age Glucose Monitoring Still Rocky,” Diagnostic Insight, pp. 4-5, 12-13, 16.
Smart, W.H. et al. (2000). “The Use of Silicon Microfabrication Technology in Painless Glucose Monitoring,” Diabetes Technology & Therapeutics 2(4):549-559.
Svedman, C. et al. (Apr. 1999). “Skin Mini-Erosion Technique for Monitoring Metabolites in Interstitial Fluid: Its Feasibility Demonstrated by OGTT Results in Diabetic and Non-Diabetic Subjects,” Scand. J. Clin. Lab. Invest. 59(2):115-123.
Trinder, P. (1969). “Determination of Glucose in Blood Using Glucose Oxidase with an Alternate Oxygen Acceptor,” Annals of Clinical Biochemistry 6:24-28.
Yum, S. I. et al. (Nov. 1, 1999). “Capillary Blood Sampling for Self-Monitoring of Blood Glucose,” Diabetes Technology & Therapeutics, 1(1):29-37.
International Search Report dated Nov. 14, 2011, for PCT Application No. PCT/US2011/001132, filed on Jun. 24, 2011, 2 pages.
Written Opinion dated Nov. 14, 2011, for PCT Application No. PCT/US2011/001132, filed on Jun. 24, 2011, 6 pages.
Final Office Action dated Apr. 30, 2013, for U.S. Appl. No. 13/168,644, filed Jun. 24, 2011, 10 pages.
Non-Final Office Action dated Jun. 22, 2012, for U.S. Appl. No. 13/168,644, filed Jun. 24, 2011, eight pages.
Non-Final Office Action dated Jan. 13, 2015, for U.S. Appl. No. 13/168,644, filed Jun. 24, 2011, 12 pages.
Brazzle, J. et al. Active Microneedles with Integrated Functionality, Solid-State Sensor and Actuator Workshop, Hilton Head Island, South Carolina, Jun. 4-8, 2000, Technical Digest, 199-202.
Burge, M.R., (Aug. 2001). “Lack of Compliance with Home Blood Glucose Monitoring Predicts Hospitalization in Diabetes”, Diabetes Care 24(8): 1502-1503.
Clarke, W.L. et al. (1981). “Evaluation of a New Reflectance Photometer for Use in Home Blood Glucose Monitoring,” Diabetes Care 4(5):547-550.
Extended European Search Report dated Apr. 19, 2011, for EP Application No. 10 18 0848.3 filed Sep. 28, 2010, 5 pages.
Extended European Search Report dated Feb. 22, 2012, for EP Application No. EP 10 18 1155, filed Sep. 28, 2010, 6 pages.
Extended European Search Report dated Jan. 22, 2013, for EP Application No. 12182900.6, filed on Sep. 29, 2006, 6 pages.
Extended European Search Report dated Jan. 22, 2015, for EP Patent Application 12820723.0, filed on Aug. 3, 2012. 4 pages.
Extended European Search Report dated Apr. 29, 2013 for EP Patent Application No. 12192620.8, filed on Nov. 14, 2012, 8 pages.
Extended European Search Report dated Nov. 8, 2016, for EP Application No. 16 167 087.2, filed on Aug. 3, 2012, 6 pages.
Extended European Search Report dated Jun. 16, 2014, for EP Application No. 09758787.7, filed on Jun. 8, 2009, 6 pages.
Extended European Search Report dated Jul. 18, 2013, for EP Application No. 06 772 943.4, filed on Jun. 13, 2006, 7 pages.
Extended European Search Report dated Oct. 27, 2016, for EP Application No. 11 798 518.4, filed on Jun. 24, 2011, 7 pages.
Extended European Search Report dated Jan. 20, 2017, for EP Application No. 14 813 126.1, filed Jun. 20, 2014, 8 pages.
Final Office Action dated Jul. 9, 2008, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 19 pages.
Final Office Action dated Nov. 23, 2009, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 20 pages.
Final Office Action dated Jan. 21, 2011, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 7 pages.
Final Office Action dated Aug. 15, 2013 for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 12 pages.
Final Office Action dated Apr. 13, 2016, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 31 pages.
Final Office Action dated Aug. 28, 2014, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 11 pages.
Final Office Action dated Dec. 26, 2014, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 9 pages.
Final Office Action dated Jan. 22, 2014, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 8 pages.
Final Office Action dated Jun. 30, 2010, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 11 pages.
Final Office Action dated May 30, 2007, for U.S. Appl. No. 11/125,107, filed May 10, 2005, 11 pages.
Final Office Action dated Nov. 1, 2010, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 9 pages.
Final Office Action dated Nov. 21, 2011, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 8 pages.
Final Office Action dated Jun. 11, 2010, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 16 pages.
Final Office Action dated Mar. 10, 2015, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 24 pages.
Final Office Action dated May 8, 2012, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 7 pages.
Final Office Action dated Mar. 27, 2014, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 10 pages.
Final Office Action dated Dec. 26, 2014, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 9 pages.
Final Office Action dated Sep. 30, 2015, for U.S. Appl. No. 13/168,644, filed Jun. 24, 2011, 16 pages.
Final Office Action dated May 5, 2016, for U.S. Appl. No. 14/311,114, filed Jun. 20, 2014, 13 pages.
Final Office Action dated May 5, 2016, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 11 pages.
Final Office Action dated Aug. 12, 2016, for U.S. Appl. No. 13/168,644, filed Jun. 24, 2011, 18 pages.
Final Office Action dated Oct. 15, 2009, for U.S. Appl. No. 11/239,122, filed Sep. 30, 2005, 13 pages.
Final Office Action dated Aug. 14, 2012, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 14 pages.
Final Office Action dated Sep. 23, 2013, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 14 pages.
Hemmerich, K.J. et al. (Apr. 1995). “Guide to Engineering Thermoplastics,” Medical Devices and Diagnostic Industry pp. 39-59.
International Search Report dated Dec. 3, 2004, for PCT Application No. PCT/US2004/08798, filed on Mar. 24, 2004, 3 pages.
International Search Report dated May 2, 2007, for PCT Application No. PCT/US2006/37923, filed on Sep. 9, 2006, 1 page.
International Search Report dated Aug. 16, 2007 for PCT Application No. PCT/US2006/038163, filed on Sep. 29, 2006, 1 page.
International Search Report dated Aug. 17, 2007 for PCT/US2006/38049, filed on Sep. 29, 2006, 1 page.
International Search Report dated Oct. 19, 2012 for PCT Application No. PCT/US2012/049629, filed on Aug. 3, 2012, 4 pages.
International Search Report dated Jul. 28, 2009, for PCT Application No. PCT/US2009/003441, filed on Jun. 8, 2009, 2 pages.
International Search Report dated Oct. 15, 2014 for PCT Application No. PCT/US2014/043516, filed on Jun. 20, 2014, 2 pages.
International Search Report dated Jan. 16, 2008, for PCT Application No. PCT/US2006/022840, filed on Jun. 13, 2006, 1 page.
Integ. (2000). “LifeGuideÔ Glucose Meter. No Lancets. No Blood,” located at <http://www.integonline.com>, last visited May 1, 2000, 10 pages.
Ishii H. et al., (Aug. 2001). “Seasonal Variation of Glycemic Control in Type 2 Diabetic Patients”, Diabetes Care 24(8):1503.
Massey V. et al. (Aug. 1960). “Studies on the Reaction Mechanism of Lipoyl Dehydrogenase” Biochim. Biophys. Acta 48: 33-47.
Non-Final Office Action dated Dec. 12, 2007, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 13 pages.
Non-Final Office Action dated Apr. 28, 2009, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 21 pages.
Non-Final Office Action dated Jun. 4, 2010, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 23 pages.
Non-Final Office Action dated Mar. 23, 2012, for U.S. Appl. No. 13/197,592, filed Aug. 3, 2011, 7 pages.
Non-Final Office Action dated Mar. 23, 2012, for U.S. Appl. No. 13/197,603, filed Aug. 3, 2011, 6 pages.
Non-Final Office Action dated Nov. 26, 2012 for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 9 pages.
Non Final Office Action dated Apr. 8, 2015, for U.S. Appl. No. 13/566,886, filed Aug. 3, 2012, 11 pages.
Non Final Office Action dated Apr. 12, 2011, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 7 pages.
Non Final Office Action dated Aug. 5, 2014, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 8 pages.
Non Final Office Action dated Dec. 5, 2014, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 7 pages.
Non Final Office Action dated Jan. 12, 2009, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 9 pages.
Non Final Office Action dated Jan. 21, 2011, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 9 pages.
Non Final Office Action dated Jul. 13, 2010, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 11 pages.
Non Final Office Action dated Jul. 31, 2015, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 16 pages.
Non Final Office Action dated Mar. 21, 2014, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 12 pages.
Non Final Office Action dated Mar. 25, 2011, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 13 pages.
Non Final Office Action dated Mar. 5, 2010, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 8 pages.
Non Final Office Action dated May 14, 2008, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 9 pages.
Non Final Office Action dated May 16, 2013, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 8 pages.
Non Final Office Action dated May 5, 2005, for U.S. Appl. No. 10/131,268, filed Apr. 23, 2002, 8 pages.
Non Final Office Action dated Nov. 2, 2006, for U.S. Appl. No. 11/125,107, filed May 10, 2005, 10 pages.
Non Final Office Action dated Oct. 14, 2009, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 10 pages.
Non Final Office Action dated Oct. 3, 2008, for U.S. Appl. No. 10/722,074, filed Nov. 24, 2003, 10 pages.
Non- Final Office Action dated Dec. 17, 2015, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 6 pages.
Non Final Office Action dated Dec. 2, 2004, for U.S. Appl. No. 10/347,620, filed Jan. 22, 2003, 8 pages.
Non-Final Office Action dated Jan. 27, 2009, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 17 pages.
Non-Final Office Action dated Jan. 6, 2014, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 12 pages.
Non-Final Office Action dated Jun. 21, 2013, for U.S. Appl. No. 13/752,261, filed Jan. 28, 2013, 12 pages.
Non-Final Office Action dated Jun. 6, 2008, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 17 pages.
Non-Final Office Action dated Oct. 9, 2014, for U.S. Appl. No. 14/446,262, filed Jul. 29, 2014, 15 pages.
Non-Final Office Action dated Sep. 29, 2004, for U.S. Appl. No. 10/394,230, filed Mar. 24, 2003, 10 pages.
Non-Final Office Action dated Nov. 23, 2011, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 6 pages.
Non-Final Office Action dated Mar. 2, 2012, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 7 pages.
Non-Final Office Action dated May 30, 2013, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 9 pages.
Non-Final Office Action dated Jun. 13, 2014, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 8 pages.
Non-Final Office Action dated Jun. 25, 2015, for U.S. Appl. No. 12/457,332, filed Jun. 8, 2009, 7 pages.
Non-Final Office Action dated Jul. 8, 2015, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 13 pages.
Non-Final Office Action dated Aug. 19, 2015, for U.S. Appl. No. 14/311,114, filed Jun. 20, 2014, 15 pages.
Non-Final Office Action dated Mar. 19, 2009, for U.S. Appl. No. 11/239,122, filed Sep. 30, 2005, 15 pages.
Non-Final Office Action dated Sep. 1, 2010, for U.S. Appl. No. 11/239,122, filed Sep. 30, 2005, 15 pages.
Non-Final Office Action dated Sep. 13, 2011, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 14 pages.
Non-Final Office Action dated Feb. 28, 2013, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 12 pages.
Non-Final Office Action dated Apr. 10, 2014, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 14 pages.
Non-Final Office Action dated May 29, 2015, for U.S. Appl. No. 14/614,177, filed Feb. 4, 2015, 13 pages.
Notice of Allowance dated May 3, 2011, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 12 pages.
Notice of Allowance dated Mar. 27, 2015, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 7 pages.
Notice of Allowance dated Apr. 18, 2012, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 8 pages.
Notice of Allowance dated Apr. 19, 2010, for U.S. Appl. No. 29/338,117, filed Jun. 4, 2009, 4 pages.
Notice of Allowance dated Aug. 3, 2012, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 5 pages.
Notice of Allowance dated Jan. 14, 2010, for U.S. Appl. No. 29/338,117, filed Jun. 4, 2009, 4 pages.
Notice of Allowance dated Jun. 29, 2012, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 5 pages.
Notice of Allowance dated Mar. 14, 2012, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 7 pages.
Notice of Allowance dated Mar. 31, 2005, for U.S. Appl. No. 10/394,230, filed Mar. 24, 2003, 10 pages.
Notice of Allowance dated May 15, 2008, for U.S. Appl. No. 11/125,107, filed May 10, 2005, 7 pages.
Notice of Allowance dated May 28, 2009, for U.S. Appl. No. 29/300,933, filed May 30, 2008, 6 pages.
Notice of Allowance dated Nov. 23, 2011, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 7 pages.
Notice of Allowance dated Nov. 27, 2012, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 5 pages.
Notice of Allowance dated Nov. 29, 2005, for U.S. Appl. No. 10/131,268, filed Apr. 23, 2002, 6 pages.
Notice of Allowance dated Oct. 12, 2011, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 8 pages.
Notice of Allowance dated Feb. 23, 2015, for U.S. Appl. No. 14/446,262, filed Jul. 29, 2014, 8 pages.
Notice of Allowance dated Feb. 5, 2014, for U.S. Appl. No. 13/752,261, filed Jan. 28, 2013, 9 pages.
Notice of Allowance dated Jun. 15, 2009, for U.S. Appl. No. 10/722,074, filed Nov. 24, 2003, 6 pages.
Notice of Allowance dated Mar. 2, 2016, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 12 pages.
Notice of Allowance dated Mar. 28, 2005, for U.S. Appl. No. 10/347,620, filed Jan. 22, 2003, 6 pages.
Notice of Allowance dated Jan. 26, 2017, for U.S. Appl. No. 12/457,331, filed Jun. 8, 2009, 7 pages.
Notice of Allowance dated Sep. 18, 2014, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 9 pages.
Notice of Allowance dated Feb. 16, 2016, for U.S. Appl. No. 14/614,177, filed Feb. 4, 2015, 7 pages.
Sonntag, O. (1993). Ektachem. Dry Chemistry, Analysis With Carrier-Bound Reagents, Elsevier Science Publishers, 57 pages.
Spielman, A. et al. (2001). Mosquito: A Natural History of Our Most Persistent and Deadly Foe, First Edition, Hyperion, New York, NY, 3 pages. (Table of Contents Only).
Straub F.B. (Mar. 1939). “Isolation and Properties of a flavoprotien from Heart Muscle Tissue”, Biochemical Journal 33: 787-792.
Tietz, N.W. (1986).Textbook of Clinical Chemistry, W. B. Saunders Company, pp. 1533 and 1556.
U.S. Precision Lens, Inc. (1983).The Handbook of Plastic Optics.
Wikipedia (2016). “Capillary action,” 7 pages.
Written Opinion dated Jul. 28, 2009, for PCT Application No. PCT/US2009/003441, filed on Jun. 8, 2009, 10 pages.
Written Opinion dated Oct. 15, 2014 for PCT Application No. PCT/US2014/043516, filed on Jun. 20, 2014, 5 pages.
Written Opinion of the International Searching Authority dated Jan. 16, 2008, for PCT Application No. PCT/US2006/022840, filed on Jun. 13, 2006, 3 pages.
Written Opinion dated Dec. 3, 2004, for PCT Application No. PCT/US2004/08798, filed on Mar. 24, 2004, 4 pages.
Written Opinion dated May 2, 2007, for PCT Application No. PCT/US2006/37923, filed on Sep. 9, 2006, 5 pages.
Written Opinion dated Aug. 17, 2007 for PCT/US2006/38049, filed on Sep. 29, 2006, 6 pages.
Written Opinion dated Aug. 16, 2007 for PCT Application No. PCT/US2006/038163, filed on Sep. 29, 2006, 4 pages.
Written Opinion dated Oct. 19, 2012 for PCT Application No. PCT/US2012/049629, filed on Aug. 3, 2012, 7 pages.
Non-Final Office Action dated Dec. 16, 2016, for U.S. Appl. No. 13/566,886, filed Aug. 3, 2012, 11 pages.
Non-Final Office Action dated Mar. 8, 2017, for U.S. Appl. No. 14/311,114, filed Jun. 20, 2014, 24 pages.
Final Office Action dated Sep. 21, 2017, for U.S. Appl. No. 13/168,644, filed Jun. 24, 2011, 14 pages.
Non-Final Office Action dated Nov. 13, 2017, for U.S. Appl. No. 14/311,114, filed Jun. 20, 2014, 15 pages.
Non-Final Office Action dated Mar. 20, 2017, by the United States Patent and Trademark Office for U.S. Appl. No. 15/191,434, filed Jun. 23, 2016, 20 pages.
Non-Final Office Action dated May 15, 2017, by the United States Patent and Trademark Office for U.S. Appl. No. 14/743,867, filed Jun. 18, 2015.
Notice of Allowance dated Aug. 18, 2017, for U.S. Appl. No. 13/566,886, filed Aug. 3, 2012, 10 pages.
Non-Final Office Action dated Mar. 21, 2017, for U.S. Appl. No. 15/177,041, filed Jun. 8, 2016, 11 pages.
Non-Final Office Action dated Sep. 29, 2017, for U.S. Appl. No. 15/499,821, filed Apr. 27, 2017, 10 pages.
Final Office Action dated Nov. 29, 2017, for U.S. Appl. No. 15/177,041, filed Jun. 8, 2016, 13 pages.
Final Office Action dated Jun. 12, 2018, for U.S. Appl. No. 15/499,821, filed Apr. 27, 2017, 12 pages.
Office Action dated Aug. 10, 2018, for U.S. Appl. No. 14/311,114, filed Jun. 20, 2014, 15 pages.
Related Publications (1)
Number Date Country
20100021948 A1 Jan 2010 US
Provisional Applications (1)
Number Date Country
61129148 Jun 2008 US